Rare Disease News

National Organization for Rare Disorders Urges Congress To Protect Funding for Rare Disease Research, Commends Exclusion of Work Requirements for Medicaid in Debt Ceiling Deal

Published June 2, 2023 by NORD

Categorized in -

Washington, DC, June 2, 2023 – This week, the Senate passed a debt ceiling deal (HR 3746) by a 63-36 vote and which now goes to President Biden for his …

Continue reading “National Organization for Rare Disorders Urges Congress To Protect Funding for Rare Disease Research, Commends Exclusion of Work Requirements for Medicaid in Debt Ceiling Deal”

National Network of NORD Rare Disease Centers of Excellence Expands to 40 U.S. Medical Institutions

Published May 4, 2023 by NORD

Categorized in -

NORD announced nine new research hospitals have been designated NORD Rare Disease Centers of Excellence, joining a network of thousands of experts committed to sharing knowledge to solve the greatest …

Continue reading “National Network of NORD Rare Disease Centers of Excellence Expands to 40 U.S. Medical Institutions”

NORD Announces 2023 Rare Impact Award Honorees and 40th Anniversary Celebration

Published February 27, 2023 by NORD

Categorized in -

May 4 Ceremony in Washington, DC will honor rare disease innovators, advocates, and partners as part of NORD’s 40th Anniversary Celebration Washington, DC, February 27, 2023—National Organization for Rare Disorders …

Continue reading “NORD Announces 2023 Rare Impact Award Honorees and 40th Anniversary Celebration”

NORD’s State Report Card Shows Progress for Rare Disease Patients, Highlights Remaining Barriers

Published February 7, 2023 by NORD

Categorized in -

Patient access to care and services improved across key policy areas in 2022, but challenges remain for the rare disease community February 7, 2023, Washington, D.C. – The National …

Continue reading “NORD’s State Report Card Shows Progress for Rare Disease Patients, Highlights Remaining Barriers”

NORD Statement on Passage of the Inflation Reduction Act

Published August 12, 2022 by NORD

Categorized in -

Washington, DC, August 12, 2022 – Following the passage of the Inflation Reduction Act, Peter L. Saltonstall, President and CEO, the National Organization for Rare Disorders (NORD), issued the following …

Continue reading “NORD Statement on Passage of the Inflation Reduction Act”

All Things Kabuki and NORD® Launch Natural History Study of Kabuki Syndrome

Published August 3, 2022 by NORD

Categorized in -

Wasilla, Alaska, August 3, 2022—All Things Kabuki and the National Organization for Rare Disorders, Inc. have launched a study with global reach to research Kabuki syndrome, which causes a variety …

Continue reading “All Things Kabuki and NORD® Launch Natural History Study of Kabuki Syndrome”

NORD Statement on Dobbs v. Jackson

Published July 6, 2022 by NORD

Categorized in -

Press Releases

Washington, DC, July 6, 2022 – NORD was founded in 1983 with the mission of improving the lives of people living with rare diseases by expanding their access to critical and timely …

Continue reading “NORD Statement on Dobbs v. Jackson”

NORD’s Living Rare Forum and Rare Impact Awards Highlight Powerful Patient Stories and Community Rock Stars

Published June 30, 2022 by NORD

Categorized in -

Press Releases

NORD’s patient centric conference showcased inspiring individuals, expert resources and presentations, and a festive celebration at the Rock and Roll Hall of Fame Cleveland, OH, June 29, 2022 – This …

Continue reading “NORD’s Living Rare Forum and Rare Impact Awards Highlight Powerful Patient Stories and Community Rock Stars”

Colorado Becomes 24th State to Establish a Rare Disease Advisory Council

Published June 9, 2022 by NORD

Categorized in -

New RDAC will help educate the public, medical professionals, and government officials about rare diseases and identify solutions to improves the lives of those living with rare diseases June 9, …

Continue reading “Colorado Becomes 24th State to Establish a Rare Disease Advisory Council”

NORD Applauds House Passage of H.R. 7667, the Food and Drug Amendments of 2022

Published June 9, 2022 by NORD

Categorized in -

WASHINGTON, June 8, 2022—Today, the U.S. House of Representatives passed by a vote of 392-28 the Food and Drug Amendments of 2022 (H.R. 7667), legislation with significant implications for millions …

Continue reading “NORD Applauds House Passage of H.R. 7667, the Food and Drug Amendments of 2022”